Profile
General Information
For the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients.
Approval Date: 1999-01-01
Date Created: 1999-01-12 12:00:00
Company Name: SmithKline Beecham
For the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients.
